تحليلات المنتج الاختيارية
بإذنك، نستخدم تحليلات محدودة تراعي الخصوصية لفهم مسارات البحث الفعالة. لا نستخدم أدوات تتبع إعلانية أو تسجيل الجلسات. يمكنك تغيير هذا الخيار في التفضيلات. اقرأ سياسة الخصوصية.
Quest Diagnostics Incorporated's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $21.1B | |
|---|---|---|
| Revenue (ttm) | 11.8B | |
| Net income (ttm) | 1.1B | |
| EPS (ttm) | $10.0 | |
| Shares out | 110M | |
| P/E (trailing) | 24.5x | |
| P/E (forward) | 16.3x | |
| Dividend | $3.44 (1.40%) | |
| Volume | 730,735 | |
| Beta | 0.54 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $10.79B | $9.88B | $9.25B | $9.87B | $11.04B | +0.6% |
| Gross profit | $4.21B | $3.43B | $3.05B | $3.24B | $3.67B | -3.4% |
| Operating income | $2.75B | $1.38B | $1.29B | $1.40B | $1.60B | -12.7% |
| Net income | $2.00B | $946.0M | $854.0M | $871.0M | $992.0M | -16.0% |
| EPS (diluted) | $15.55 | $7.97 | $7.49 | $7.69 | $8.75 | -13.4% |
| EBITDA | $3.16B | $1.82B | $1.73B | $1.89B | $2.17B | -9.0% |
| R&D | — | — | — | — | — | — |
| SG&A | $1.73B | $1.87B | $1.64B | $1.77B | $1.97B | +3.3% |
Recent company headlines from major financial publishers.
Accretive hospital lab system acquisitions, expansion in advanced and esoteric testing (e.g., Alzheimer's, cancer), and continued realization of cost synergies lead to margin expansion and faster-than-expected organic growth.
Quest Diagnostics is a mature, highly cash-generative leader in the US diagnostic testing market. Its robust national network provides durable scale advantages, supporting consistent free cash flow generation and a reliable, growing dividend.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 4.3% | $308 | $375 | $396 | $396 | $396 |
| 5.3% | $226 | $261 | $308 | $375 | $396 |
| 6.3% | $179 | $200 | $226 | $261 | $308 |
| 7.3% | $148 | $162 | $179 | $200 | $226 |
| 8.3% | $126 | $136 | $148 | $162 | $179 |
Upcoming earnings date and setup when available.
التصنيف الذي حملته نسخة البحث المنشورة في كل شهر. يقارن التصنيف السعر في تاريخ التحليل بالقيمة العادلة، وليس سجلاً لمدى صحة التقدير.
| السنة | يناير | فبراير | مارس | أبريل | مايو | يونيو | يوليو | أغسطس | سبتمبر | أكتوبر | نوفمبر | ديسمبر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
